- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.11.25 | Filament Health Announces Third Quarter 2025 Financial Results And Operational Highlights | 4 | CNW | ||
| 11.08.25 | Filament Health Corp. reports Q2 results | 2 | Seeking Alpha | ||
| 11.08.25 | Filament Health Announces Second Quarter 2025 Financial Results And Operational Highlights | 1 | CNW | ||
| 31.07.25 | Filament Health Announces First-ever Compassionate Use Approval For Psilocybin In The European Union | 1 | CNW | ||
| 24.07.25 | Filament Health Announces Two Phase 2 Research Trials In Partnership With University College London | 1 | CNW | ||
| 08.07.25 | Jaguar Health, Inc.: Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health | 572 | ACCESS Newswire | Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2025 /
Jaguar Health, Inc.
(NASDAQ:JAGX)
... ► Artikel lesen | |
| 22.05.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025 | 843 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT... ► Artikel lesen | |
| 22.05.25 | XFRA 7QS: AUSSETZUNG/SUSPENSION | 281 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen | |
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 19.05.25 | Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada | 233 | PR Newswire | VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 09.05.25 | Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights | 151 | PR Newswire | VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 04.04.25 | Filament Health Corp.: Filament Health Announces Private Placement And Intention To Voluntarily Delist From Cboe Canada | 212 | PR Newswire | Financing driven by existing investor Negev and Filament's Board of Directors
Company also announces intention to voluntarily delist from Cboe Canada
VANCOUVER... ► Artikel lesen | |
| 01.04.25 | Filament Health Corp.: Filament Health Reports Q4 And Year End 2024 Financial Results And Operational Highlights | 171 | PR Newswire | VANCOUVER, BC, April 1, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 17.03.25 | Filament Health Corp.: Filament Health Announces Positive Data From Phase 2 Study Of Pex010 In Patients With Alcohol Use Disorder | 162 | PR Newswire | Open-label study at Psychiatric Centre Copenhagen found that alcohol consumption significantly decreased amongst participants dosed with Filament's botanical psilocybin... ► Artikel lesen | |
| 06.02.25 | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference | 548 | ACCESS Newswire | Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 43,785 | -1,39 % | DAX-Check LIVE: Bayer, Deutsche Bank, DHL Group, Lufthansa, SAP, Schaeffler, Verbio im Fokus | Der DAX hat seine Rekordserie fortgesetzt, zeigte dabei aber spürbar höhere Ausschläge. Auslöser waren US-Inflationsdaten, die den Leitindex im Tagesverlauf auf ein neues Hoch von 25.505 Punkten trieben.... ► Artikel lesen | |
| AURORA CANNABIS | 3,640 | +0,97 % | Aurora Cannabis Inc (3): Aurora Cannabis conducts powdery mildew research | ||
| CANOPY GROWTH | 1,034 | +2,78 % | Warum Aktien aus dem Bereich medizinisches Cannabis vor einem Comeback stehen könnten. Canopy Growth, Bioxyne und Tilray im Fokus. | ||
| TILRAY BRANDS | 7,770 | -2,75 % | D-Wave Quantum, Silver Viper, Tilray Brands - Das Jahr der Entscheidungen | 2026 könnte für Anleger ein Jahr der großen Weichenstellungen werden. Geopolitische Spannungen, fragile Lieferketten und wachsende Schuldenberge sprechen dafür, dass Edelmetalle weiter ganz oben auf... ► Artikel lesen | |
| INNOCAN PHARMA | 4,940 | -0,80 % | INNOCAN PHARMA CORPORATION: Strukturelle Ruhe, klare Linie | ||
| CRONOS GROUP | 2,144 | -2,19 % | Bernstein hebt Kursziel für Cronos Group wegen Wachstumskurs auf 2,30 US-Dollar an | ||
| SYNBIOTIC | 2,630 | -1,50 % | Original-Research: SYNBIOTIC SE (von NuWays AG): BUY | Original-Research: SYNBIOTIC SE - from NuWays AG
19.12.2025 / 09:26 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,805 | -3,27 % | Tilray, Green Thumb & Co: Trump lockert Cannabis-Regeln | US-Präsident Donald Trump hat mit einer neuen Executive Order einen tiefgreifenden Kurswechsel in der amerikanischen Cannabispolitik angestoßen. Künftig soll Marihuana nicht mehr in die strengste Kategorie... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,017 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake closes sale of Christina Lake land | ||
| AXSOME THERAPEUTICS | 148,40 | -1,72 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia | NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 145,15 | +0,94 % | Boehringer Ingelheim Limited: Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer | Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients
Ingelheim, Germany- 12 January, 2026 - Boehringer Ingelheim today announced a strategic... ► Artikel lesen | |
| JAGUAR HEALTH | 1,430 | +87,05 % | Jaguar Health, Inc.: Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts | SAN FRANCISCO, CA / ACCESS Newswire / January 14, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday... ► Artikel lesen | |
| TRULIEVE CANNABIS | 7,025 | -2,23 % | TRULIEVE CANNABIS CORP - Stabilität als Signal | ||
| CORBUS PHARMACEUTICALS | 7,200 | +1,41 % | Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss | CRB-913 was safe and well-tolerated across all doses studiedDaily neuropsychiatric assessments using CSSRS, PHQ-9, and GAD-7 were negative for all participantsA placebo-adjusted mean weight loss of... ► Artikel lesen | |
| AVALO THERAPEUTICS | 12,660 | -1,40 % | Avalo Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of trial data |
FILAMENT HEALTH CORP gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,010 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FILAMENT HEALTH CORP finden Sie auf Wallstreet Online.